1. Home
  2. DRIO vs LSTA Comparison

DRIO vs LSTA Comparison

Compare DRIO & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DarioHealth Corp.

DRIO

DarioHealth Corp.

HOLD

Current Price

$1.32

Market Cap

18.5M

Sector

Health Care

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

SELL

Current Price

$0.90

Market Cap

15.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
DRIO
LSTA
Founded
2011
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Misc Health and Biotechnology Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.5M
15.9M
IPO Year
2013
2000

Fundamental Metrics

Financial Performance
Metric
DRIO
LSTA
Price
$1.32
$0.90
Analyst Decision
Strong Buy
Hold
Analyst Count
5
2
Target Price
★ $8.00
N/A
AVG Volume (30 Days)
73.3K
★ 132.4K
Earning Date
11-12-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1559.02
20.42
EPS
★ 2.46
N/A
Revenue
$7,394,000.00
★ $35,283,868.00
Revenue This Year
N/A
N/A
Revenue Next Year
$32.43
N/A
P/E Ratio
$0.59
★ N/A
Revenue Growth
43.02
★ 56.90
52 Week Low
$1.09
$0.86
52 Week High
$14.49
$5.07

Technical Indicators

Market Signals
Indicator
DRIO
LSTA
Relative Strength Index (RSI) 24.17 37.62
Support Level N/A N/A
Resistance Level $8.01 $1.28
Average True Range (ATR) 0.47 0.13
MACD 0.01 -0.01
Stochastic Oscillator 11.00 6.83

Price Performance

Historical Comparison
DRIO
LSTA

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: